MedPath

Cognitive Impairement In Frontotemporal Dementia

Completed
Conditions
Frontotemporal Degeneration
Progressive Supranuclear Palsy
Multiple System Atrophy
Interventions
Other: None-Observation Only
Registration Number
NCT03452956
Lead Sponsor
University of Pennsylvania
Brief Summary

This is an observational study that aims to better understand the genetic causes of frontotemporal degeneration (FTD), Multiple Systems Atrophy (MSA), and Progressive Supranuclear Palsy (PSP). It is hoped the information gathered in this study will help lead to better diagnostics and future treatments.

Detailed Description

Comparative and longitudinal studies reveal clinical differences between subgroups of patients with frontotemporal dementia (FTD), including Progressive Non-fluent Aphasia (PNFA), Semantic Dementia (SD), patients with a disorder of social comportment and personality (SOC), and non-aphasic patients with executive dysfunction (EXEC). MRI studies of cortical atrophy and fMRI studies show correlated neural defects in FTD subgroups. The investigators will obtain converging evidence from multiple sources to test hypotheses about the neural basis for cognitive functions such as semantic memory, grammatical processing, and social functioning in these FTD subgroups, while improving clinical care for these patients. Recent studies have linked progressive supra nuclear palsy (PSP) and multiple systems atrophy (MSA) to FTD. The investigators will obtain comparable neuropsychological and biomarker data in order to compare these patient groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
997
Inclusion Criteria
  • Individuals who have been diagnosed with FTD, PSP, and MSA
Read More
Exclusion Criteria
  • Individuals under 18 years of age
  • People with pacemakers or certain metallic implants
  • pregnant women
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
FTD CohortNone-Observation OnlyNo intervention-observation only
Primary Outcome Measures
NameTimeMethod
ProgressionThis is a natural history study - participants are followed from date of enrollment until death, withdrawl, or funding is no longer available, or until 984 months have passed

Changes over time in MRI and cognitive testing data.

Secondary Outcome Measures
NameTimeMethod
Impaired semantic memory in Semantic Dementia (SD).This is a natural history study - participants are followed from date of enrollment until death, withdrawl, or funding is no longer available, or until 984 months have passed

The impact of cortical atrophy on language processing.

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath